217 related articles for article (PubMed ID: 36653904)
21. Clinical and genomic analyses of neuroendocrine neoplasms of the breast.
Wei Y; Ke X; Yu J; Jing Q; Bu H; Zeng X; Wei B
Mod Pathol; 2022 Apr; 35(4):495-505. PubMed ID: 34728787
[TBL] [Abstract][Full Text] [Related]
22. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract][Full Text] [Related]
23. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
Klöppel G
Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
[TBL] [Abstract][Full Text] [Related]
24. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
Sun TY; Hendifar A; Padda SK
Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
[TBL] [Abstract][Full Text] [Related]
25. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
[TBL] [Abstract][Full Text] [Related]
26. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors.
Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N
Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886
[TBL] [Abstract][Full Text] [Related]
27. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
28. Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.
Zakka K; Nagy R; Drusbosky L; Akce M; Wu C; Alese OB; El-Rayes BF; Kasi PM; Mody K; Starr J; Shaib WL
Oncotarget; 2020 May; 11(19):1749-1757. PubMed ID: 32477464
[No Abstract] [Full Text] [Related]
29. Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).
Puccini A; Poorman K; Salem ME; Soldato D; Seeber A; Goldberg RM; Shields AF; Xiu J; Battaglin F; Berger MD; Tokunaga R; Naseem M; Barzi A; Iqbal S; Zhang W; Soni S; Hwang JJ; Philip PA; Sciallero S; Korn WM; Marshall JL; Lenz HJ
Clin Cancer Res; 2020 Nov; 26(22):5943-5951. PubMed ID: 32883742
[TBL] [Abstract][Full Text] [Related]
30. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
Yachida S; Vakiani E; White CM; Zhong Y; Saunders T; Morgan R; de Wilde RF; Maitra A; Hicks J; Demarzo AM; Shi C; Sharma R; Laheru D; Edil BH; Wolfgang CL; Schulick RD; Hruban RH; Tang LH; Klimstra DS; Iacobuzio-Donahue CA
Am J Surg Pathol; 2012 Feb; 36(2):173-84. PubMed ID: 22251937
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.
Gajate P; Alonso-Gordoa T; Martínez-Sáez O; Molina-Cerrillo J; Grande E
Clin Transl Oncol; 2018 May; 20(5):561-569. PubMed ID: 29124519
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Bal M; Sharma A; Rane SU; Mittal N; Chaukar D; Prabhash K; Patil A
Head Neck Pathol; 2022 Jun; 16(2):375-387. PubMed ID: 34401980
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
[TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing of rectal neuroendocrine tumors.
Li Y; Guo Y; Cheng Z; Tian C; Chen Y; Chen R; Yu F; Shi Y; Su F; Zhao S; Wang Z; Luo J; Tan H
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 36645718
[TBL] [Abstract][Full Text] [Related]
35. mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs).
Zanini S; Renzi S; Giovinazzo F; Bermano G
Front Endocrinol (Lausanne); 2020; 11():562505. PubMed ID: 33304317
[TBL] [Abstract][Full Text] [Related]
36. O
Watanabe H; Yamazaki Y; Fujishima F; Izumi K; Imamura M; Hijioka S; Toriyama K; Yatabe Y; Kudo A; Motoi F; Unno M; Sasano H
BMC Cancer; 2020 Dec; 20(1):1195. PubMed ID: 33287738
[TBL] [Abstract][Full Text] [Related]
37. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
38. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
Yu S; Hornick JL; Gonzalez RS
Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
[TBL] [Abstract][Full Text] [Related]
39. Genomic dissection of gastrointestinal and lung neuroendocrine neoplasm.
Wang H; Sun L; Bao H; Wang A; Zhang P; Wu X; Tong X; Wang X; Luo J; Shen L; Shao YW; Lu M
Chin J Cancer Res; 2019 Dec; 31(6):918-929. PubMed ID: 31949394
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]